Abstract
Candiduria, due to Candida albicans, Candida glabrata and other organisms, has increased in frequency due the use of broad-spectrum antibacterials, immunosuppressive agents and other factors. The optimal management of candiduria is unknown due to an undlear definition of fungal urinary tract infection and the lack of well-designed clinical trials. Removal of urinary catheters, ruling out obstruction/stones and documenting presence of post-void residuals are useful in the management of candiduria. Amphotericin B bladder irrigants and oral fluconazole may be used in certain patients who are high risk or with persistence of candiduria after removal of the urinary catheter.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
